Publication,

Improved trade deal between Japan and ASEAN

AU | EN
Current site :    AU   |   EN
Australia
Belgium
China
China Hong Kong SAR
Germany
Italy
Japan
Singapore
Spain
UAE
United Kingdom
United States
Global

According to data from the Japanese Finance Ministry, ASEAN as a whole was Japan's third-largest trade partner after China and the United States in 2019, with exports to the bloc totalling 11.58 trillion yen and imports worth 11.76 trillion yen. 

We expect to see even more cross-border trade and investments between Japan and ASEAN Member States as a result of the coming into force of the First Protocol to amend the ASEAN-Japan Comprehensive Economic Partnership Agreement ("AJCEPA") on 1 August 2020. 

The amended AJCEPA currently applies among the countries that have completed the necessary internal procedures and have notified the other signatories that its internal legal procedures are complete, being Japan, Thailand, Singapore, Laos, Myanmar, Vietnam and Brunei.  The remaining four ASEAN member states, Cambodia, Indonesia, Malaysia and the Philippines, are expected to complete procedures and join by the end of 2020.

Download
Improved trade deal between Japan and ASEAN

Download

396KB, 4 Pages

LATEST THINKING
Insight
On 2 August 2022, the Aged Care and Other Legislation Amendment (Royal Commission Response) Bill 2022 was passed (Aged Care Bill), introducing important regulatory changes to Australia’s aged care sector. The Bill makes numerous legislative amendments, including to the Aged Care Act 1997 (Cth) (Aged Care Act) and the Aged Care (Transitional Provisions) Act 1997 (Cth) (Transitional Provisions Act), and responds to various recommendations made by the Royal Commission into Aged Care Quality and Safety (Royal Commission) Final Report (Report). The Report identified the provision of substandard aged care services and perceived systemic failures in the aged care sector.[1]

08 August 2022

Insight
The Federal Court has refused an application to stay proceedings to quantify compensation for patent infringement (quantum proceedings) pending the outcome of separate parallel proceedings challenging the validity of the infringed patent on new grounds. The case is significant as intellectual property cases are regularly bifurcated with liability determined separately damages or an account of profits. A patentee may also bring consecutive infringement cases and therefore have two separate cases considering invalidity issues for the same patent running in parallel.

03 August 2022

Insight
Since the introduction of a nationwide Marketing Authorization Holder (MAH) system in 2019, licenses have linked directly to therapeutic products rather than manufacturers.

03 August 2022